Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 670 shares at $83.00 ($56K) on 2017-09-11, disclosed to the SEC on 2017-09-12.
Open-market sale of $56k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |